The increase in those surrogate markers of insulin resistance were primarily driven by hyperinsulinemia in the ERaKOs in response to HFD; ERaKOs fed HFD exhibited a fourfold increase in fasting insulin compared to NC (G×D, P = 0.036) (Table 2). The gene discussed is INS; the disease is hyperinsulinism.